| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/25/2009 | CA2706502A1 Antibodies recognizing a carbohydrate containing epitope on cd-43 and cea expressed on cancer cells and methods using same |
| 06/24/2009 | EP2072619A1 Factor involved in metastasis and uses thereof |
| 06/24/2009 | EP2072059A1 Use of bispecific antibodies to regulate immune responses |
| 06/24/2009 | EP2072045A2 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease |
| 06/24/2009 | EP1987161A4 Method to identify cd40-sensitive cells |
| 06/24/2009 | EP1801119B1 Interleukin-15 antagonist peptide |
| 06/24/2009 | EP1716168A4 Detection of urinary mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of mesothelioma |
| 06/24/2009 | EP1706145B1 Autoantibodies utilized as carrier agents for pharmaceutical compounds used in tumor imaging and cancer treatment |
| 06/24/2009 | EP1654286B1 Humanized anti-cd4 antibody with immunosuppressive properties |
| 06/24/2009 | EP1575522B1 Methods for treating pain by administering an antagonist antibody against the nerve growth factor and an opioid analgesic and compositions containing the same |
| 06/24/2009 | EP1451333B1 Ul16 binding protein 4 |
| 06/24/2009 | EP1429650B1 Alternatively spliced circulating tissue factor |
| 06/24/2009 | EP1303591B1 Masp-2, a complement-fixing enzyme, and uses for it |
| 06/24/2009 | EP1131106B1 Compositions and methods for producing vascular occlusion |
| 06/24/2009 | CN101466737A Targeted binding agents directed to uPAR and uses thereof |
| 06/24/2009 | CN101466736A Therapy targeting cathepsin S |
| 06/24/2009 | CN101466735A Treatment of multiple sclerosis and/or rheumatoid arthritis |
| 06/24/2009 | CN101466734A Competitive domain antibody formats that bind interleukin 1 receptor type 1 |
| 06/24/2009 | CN101466733A Binding proteins comprising immunoglobulin hinge and Fc regions having altered Fc effector functions |
| 06/24/2009 | CN101463088A Anti-soman antibody |
| 06/24/2009 | CN101463087A Anti-ricin antibody |
| 06/24/2009 | CN101463086A Diethoxy thiophosphate organophosphorus pesticide antibody, and preparation and use thereof |
| 06/24/2009 | CN101463085A Gene engineering monoclonal antibody combined with A-beta oligomer specificity |
| 06/24/2009 | CN101463084A Gene engineering monoclonal antibody combined with A-beta oligomer specificity |
| 06/24/2009 | CN101463083A Gene engineering monoclonal antibody combined with A-beta oligomer specificity |
| 06/24/2009 | CN101463082A Gene engineering monoclonal antibody combined with A-beta oligomer specificity |
| 06/24/2009 | CN100503828C Variable region of monoclonal antibody against HBV s-surface antigen and gene encoding same |
| 06/24/2009 | CN100503639C Recombinant tumor specific antibody and use thereof |
| 06/24/2009 | CN100503638C Protein tau |
| 06/23/2009 | US7550650 Production of a transgenic avian by cytoplasmic injection |
| 06/23/2009 | US7550647 Transfected shrimp as production systems for therapeutic proteins |
| 06/23/2009 | US7550609 Biological conjugates for tumor targeted treatment; novel taxanes having mercapto or disulfide groups; side effect reduction without compromising their cytotoxicity |
| 06/23/2009 | US7550573 Nucleotide sequences coding polypeptides for use in the treatment of thrombosis, arthritis and cell proliferation defects |
| 06/23/2009 | US7550569 Antibodies that specifically bind to GMAD |
| 06/23/2009 | US7550568 Monoclonal antibodies to human high molecular weight-melanoma associated antigen |
| 06/23/2009 | US7550562 Having pathogenic activity that can induce pemphigus lesion; a peptide specifically recognized by the monoclonal antibody and useful as a therapeutic drug for pemphigus autoimmune disease; drug screening |
| 06/23/2009 | US7550438 culture product protein obtained from culturing kidney epithelial cells of BSC-1 African green monkey kidney epithelial cell line; for perfusing ex vivo a donor human kidney, intended for transplantation into a new host; treating and diagnosing patients with kidney disease |
| 06/23/2009 | US7550429 treating mammal to a weight reduction or reduction in obesity; biodrug as antilipolytic agents |
| 06/23/2009 | US7550280 Lipases and uses thereof |
| 06/23/2009 | US7550268 THROUGH USE OF EPITOPE DETECTOR CONTAINING SINGLE CHAIN FV OR CONSTRAINED EPITOPE SPECIFIC CDR ATTACHED TO AN OLIGONUCLEOTIDE; kits |
| 06/23/2009 | US7550144 Antibody capable of reacting with cellular prion protein (PrP) ; for prevention of prion replication; for treatment or prevention of neuropathology such as Creutzfeldt-Jacob Disease |
| 06/23/2009 | US7550143 Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses |
| 06/23/2009 | US7550142 Anti-integrin antibodies, compositions, methods and uses |
| 06/23/2009 | US7550140 Stimulation of human T-cells and used to enhance antigen-specific immune responses; immunotherapy |
| 06/23/2009 | CA2387267C Methods of optimizing antibody variable region binding affinity |
| 06/23/2009 | CA2173822C Cytoplasmic expression of antibodies, antibody fragments and antibody fragment fusion molecules in e. coli |
| 06/23/2009 | CA2139100C New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents |
| 06/18/2009 | WO2009076632A1 Compositions and methods for early pregnancy diagnosis |
| 06/18/2009 | WO2009076463A1 Nk-1 receptor mediated delivery of agents to cells |
| 06/18/2009 | WO2009075881A2 Impaired wound healing compositions and treatments |
| 06/18/2009 | WO2009075836A2 Rap variants for drug delivery |
| 06/18/2009 | WO2009075646A1 Improved immunizing composition |
| 06/18/2009 | WO2009075376A1 Anti-ofloxacin monoclonal antibody and immunoassay method of ofloxacin using the same |
| 06/18/2009 | WO2009075084A1 Agent and method for diagnosis on the occurrence of alzheimer's disease or the tendency to develop alzheimer's disease |
| 06/18/2009 | WO2009074634A2 Polypeptides, antibody variable domains & antagonists |
| 06/18/2009 | WO2009074583A1 Antigen binding proteins |
| 06/18/2009 | WO2009074339A1 Remedies for pemphigus containing anti fas ligand antobodies |
| 06/18/2009 | WO2009074325A1 Transgenic plants modified for reduced cadmium transport, derivative products, and related methods |
| 06/18/2009 | WO2009074318A2 Novel rubella e1 envelope protein variants and their use in the detection of anti-rubella antibodies |
| 06/18/2009 | WO2009053637A3 Anti-ricin antibody |
| 06/18/2009 | WO2009043173A8 Cc2d2a gene mutations associated with joubert syndrome and diagnostic methods for identifying the same |
| 06/18/2009 | WO2009039507A3 Identification and isolation of fetal cells and nucleic acid |
| 06/18/2009 | WO2009021754A3 Monospecific and multispecific antibodies and method of use |
| 06/18/2009 | WO2009010296A3 Antibodies against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and metabolites thereof |
| 06/18/2009 | WO2007109749A8 Methods for preventing and treating amyloidogenic diseases |
| 06/18/2009 | WO2007021841A3 Identification and engineering of antibodies with variant fc regions and methods of using same |
| 06/18/2009 | WO2004024077A3 Novel composition and methods for the treatment of psoriasis |
| 06/18/2009 | WO2003074664A3 Cloning and characterization of slc26a7 and slc26a9 anion exchangers |
| 06/18/2009 | WO2003072756A3 Cloning and characterization of slc26a8 and slc26a11 anion exchangers |
| 06/18/2009 | WO2003066830A3 Human monoclonal antibodies against membrane proteins |
| 06/18/2009 | WO2002079494A3 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof |
| 06/18/2009 | WO2001085908A3 Clasp-1 transmembrane protein |
| 06/18/2009 | US20090158451 Indoleamine 2,3-Dioxygenase-2 |
| 06/18/2009 | US20090158448 Dna encoding polypeptide capable of modulating muscle-specific tyrosine kinase activity |
| 06/18/2009 | US20090156801 Biomolecule labeling reactants based on azacycloalkanes and conjugates derived thereof |
| 06/18/2009 | US20090156790 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 06/18/2009 | US20090156789 Compositions, Methods and Kits Useful for the Diagnosis and Treatment of Spinal Muscular Atrophy |
| 06/18/2009 | US20090156788 monoclonal antibody, or antigen binding fragment thereof that binds to human IL-23p19 at an epitope comprising residues 133-140 of SEQ ID NO: 29; treatment of inflammatory, autoimmune, and proliferative disorders |
| 06/18/2009 | US20090156787 Antibody production elicited by a dna vaccine delivered by electroporation |
| 06/18/2009 | US20090156786 Mammalian Genes: Related Reagents and Methods |
| 06/18/2009 | US20090156536 AIMP2-DX2 Gene and SiRNA Targeting AIMP2-DX2 |
| 06/18/2009 | US20090156506 determining Vascular Endothelial Growth Factor D (VEGF-D) concentration in a sample from human that has tuberous sclerosis complex (TSC) or a cystic or chylous lung disorder such as lymphangiomatosis, Pulmonary Langerhan's cell histiocytosis (PLCH), emphysema, Sjogren's syndrome with cystic lung disease |
| 06/18/2009 | US20090156493 Urocortin-iii and uses thereof |
| 06/18/2009 | US20090156475 Gene defects and mutant ALK kinase in human solid tumors |
| 06/18/2009 | US20090156414 Genetic Analysis in Racing Animals |
| 06/18/2009 | US20090155930 Monoclonal antibody ds6, tumor-associated antigen ca6, and methods of use thereof |
| 06/18/2009 | US20090155928 Modulating robo: ligand interactions |
| 06/18/2009 | US20090155897 Glycoprotein vi fusion proteins |
| 06/18/2009 | US20090155896 Human Cancer Suppressor Gene, Protein Encoded Therein, Expression Vector Containing The Same, And Cell Transformed By The Vector |
| 06/18/2009 | US20090155886 Nucleic acids and polypeptides specific for pathogenic strains of the neisseria genus |
| 06/18/2009 | US20090155850 Horse:Human Chimeric Antibodies |
| 06/18/2009 | US20090155849 Generation of specific adhesion in gram-negative bacteria by means of anchoring immunoglobulin single domains on their surface with autotransporters |
| 06/18/2009 | US20090155824 Methods for antibody engineering |
| 06/18/2009 | US20090155817 Genetic products differentially expressed in tumors and the use thereof |
| 06/18/2009 | US20090155810 Methods for producing members of specific binding pairs |
| 06/18/2009 | US20090155807 C-met mutations in lung cancer |
| 06/18/2009 | US20090155806 identifying biallelic markers of a FLAP gene and the association established between these markers and diseases involving the leukotriene pathway such as asthma |
| 06/18/2009 | US20090155799 Methods for diagnosing pancreatic cancer using reg4 protein |
| 06/18/2009 | US20090155797 Methods For Generating Enhanced Antibody-Producing Cell Lines With Improved Growth Characteristics |
| 06/18/2009 | US20090155778 Mental Disorder-Related Gene and Use of the Same |